Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Use of EVUSHELD as Pre-exposure Prophylaxis in Real-world Setting - A Multi-center Observational Prospective Study to Determine Utilization and Clinical Outcomes of EVUSHELD in Gulf Cooperation Council Countries

NCT05315323 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05315323
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05315323 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Use of EVUSHELD as Pre-exposure Prophylaxis in Real-world Setting - A Multi-center Observational Prospective Study to Determine Utilization and Clinical Outcomes of EVUSHELD in Gulf Cooperation Council Countries
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
June 23, 2022
Completion date
June 27, 2024
Enrollment
550 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19